None listed
Conditions
Interventions
None listed
Sponsors
MSD Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Sexually active (at least for last one year) females, 35â??50 years of age, with at least one daughter of age between 9-18 years (both inclusive) 2. Women who have normal menstrual cycles or no bleeding after intercourse, OR Women who have abnormal bleeding or bleeding after intercourse 3. Able and willing to attend the counselling of cervical cancer 4. Able to fill the questionnaires used in this study 5. Able to give a written informed consent
Exclusion criteria
Exclusion criteria: 1. Pregnant Females 2. Females who are already vaccinated for HPV infection 3. Females whose daughter(s) aged 9-18 years are already vaccinated for HPV infection 4. Use of intra-vaginal medication within 24 hours prior to enrolment. 5. Actively menstruating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of willingness for daughterâ??s HPV vaccination based on results of motherâ??s screening for HPV infectionTimepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Analysis of willingness for self HPV screening after counselling for cervical cancer and its prevention 2. Analysis of willingness for self HPV vaccination after counselling for cervical cancer and its prevention 3. Analysis of willingness for daughterâ??s vaccination after counselling for cervical cancer and its prevention 4. Analysis of willingness for self HPV vaccination based on results of self HPV screening Timepoint: 12 months;5. Comparison of willingness for daughterâ??s HPV vaccination after motherâ??s screening for HPV according to subjectâ??s socio-economic class 6. Comparison of willingness of daughterâ??s vaccination â?? pre HPV screening versus post HPV screening 7. Comparison of willingness for self HPV vaccination after screening for HPV according to subjectâ??s socio-economic class 8. Analysis of the HPV genotypes present in the subject.Timepoint: 12 months;9. Analysis of barriers for self HPV vaccination 10. Analysis of barriers for daughterâ??s HPV vaccinationTimepoint: 12 months | — |
Countries
India
Contacts
Public ContactNarendra Patil
Outcome results
None listed